Trending News Today: FDA Green Lights Late-Stage Trial for Non-Opioid Painkiller

Pharmaceutical company PainReform has received approval from the FDA to begin late-stage clinical trials for a non-opiate pain relief drug, Reuters reported. According to the article, two phase 3 trials will investigate the product PRF-110, which prolongs the action of ropivacaine, a local analgesic, and will focus on post-operative pain relief in soft and hard tissue. In an earlier study, PRF-110 relieved pain for up to 72 hours, which is 10 times longer than the standard of care, the article reported.
A new study found that women who work long hours may be at an increased risk for diabetes, the New York Times reported. According to the article, researchers studied 7065 workers following their work hours and health over an average of 12 years, and recorded diabetes diagnoses beginning 2 years after the participants were enrolled. Compared with women who worked 35 and 40 hours a week, those who worked 45 hours or more had a 51% increased risk of diabetes, according to the study’s results.  
On Tuesday, Pfizer Inc said it was delaying its drug price hikes that went into effect on July 1 after discussions with President Donald Trump, Reuters reported. According to the article, Pfizer said that it would defer price increases until the end of the year or until the president’s drug pricing blueprint goes into effect. Pfizer plans to return drug prices to their pre-July 1 levels as soon as possible, the article reported.

Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 

Most Popular

Related Articles

Top news of the day across the health care landscape.
Top news of the day across the health care landscape.
Top news of the day across the health care landscape.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.